The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making ...

CRC is an aggressive cancer with a low survivability rate when diagnosed at stage 4, when it has a survivability of 11% to 13 ...

Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Johnson & Johnson MedTech has launched Dualto Energy System. which unites various energy modalities into an “integrated” platform ...

Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access ...

Abbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.

Alcon has signed a definitive merger agreement to acquire Lensar to enhance its portfolio of cataract equipment and technology.

Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection to advance cancer ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

The FDA has granted 510(k) approval for UK-based Huntleigh Healthcare’s Dawes-Redman CTG Analysis for foetal monitoring ...

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

23andMe has filed for bankruptcy protection in the US as the failing business attempts to materialise what little value it ...